nyiminhan
@nyiminhan.bsky.social
Nephrologist from Myanmar, passionate to do interventions
Reposted by nyiminhan
PROTECT is a large, international, randomized, double-blind, active-controlled Phase 3 trial to assess the efficacy and safety of sparsentan versus irbesartan
#Nephpearls #KidneyWk
#Nephpearls #KidneyWk
December 5, 2024 at 5:04 AM
PROTECT is a large, international, randomized, double-blind, active-controlled Phase 3 trial to assess the efficacy and safety of sparsentan versus irbesartan
#Nephpearls #KidneyWk
#Nephpearls #KidneyWk